Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Wear Your Medicine: Nufabrx® and Enventys Partners Join Forces to Transform Healthcare with HealthWear®


News provided by

Enventys Partners

Aug 07, 2023, 13:25 ET

Share this article

Share toX

Share this article

Share toX


Nufabrx® HealthWear® and Enventys Partners announce partnership to bring wellness to consumers through a new technology that delivers doses of medicine through clothing.

CHARLOTTE, N.C., Aug. 7, 2023 /PRNewswire-PRWeb/ -- Getting healthy has never been easier! Nufabrx® and Enventys Partners announce a partnership to bring new innovation to people faster than ever before through HealthWear®, a platform technology delivering medicine, health and wellness to consumers via clothing.

Nufabrx is the first company to deliver doses of medicine through clothing, creating an entirely new category called HealthWear®. This patented, smart-textile platform puts active ingredients directly into textile products. Knitted into the composition of HealthWear, the finished garments consistently deliver small amounts of topical treatments to the skin that are activated by body heat and/or moisture. Garments built with HealthWear technology provide a therapeutic amount of treatment even after repeated uses, wears and launderings.

We're bringing together the best of both worlds - Nufabrx's groundbreaking HealthWear technology and our proven product launch process. This partnership is not just about creating new products, it's about enhancing lives and making wellness an effortless part of the everyday routine.

Post this

"Innovation is in our DNA, so partnering with a company like Nufabrx allows us to leverage our best-of-class product development and launch capabilities to create new products using the proprietary technology of Nufabrx and bring them to market to benefit consumers," said the founder and Chief Executive of Enventys, Louis Foreman. "Their technology will create endless opportunities."

HealthWear technology is reshaping the way consumers think about their clothing. Instead of buying a garment based on color, brand or size, it's now about the health benefit people can achieve. HealthWear offers a range of benefits, like a topical analgesic-infused compression sleeve to reduce pain, shea butter infused yoga pants and antifungal socks. This newly formed partnership allows Nufabrx & Enventys Partners to bring this new technology to stores nationwide and internationally, more quickly and in various clothing formats.

"This partnership represents a significant step forward in our mission to bring innovative and beneficial products to consumers," said Enventys Partners President and co-founder, Roy Morejon. "We're bringing together the best of both worlds - Nufabrx's groundbreaking HealthWear technology and our proven product launch process. This partnership is not just about creating new products, it's about enhancing lives and making wellness an effortless part of the everyday routine."

"Getting healthy has never been easier, just get dressed in the morning with your favorite vitamins, supplements and medications! The future of drug delivery is here today," said Nufabrx CEO, Jordan Schindler. "We're extremely excited to partner with a market leading innovator, Enventys Partners, to bring exciting and new game-changing HealthWear products to consumers faster than ever before!"

To learn more, or to schedule an interview with Roy Morejon, Louis Foreman or Jordan Schindler, please email [email protected].

About NUFABRX®
Nufabrx® is a state-of-the-art, patented platform technology called HealthWear®, created by award-winning designers and PhD scientists that infuses active ingredients into textiles. HealthWear®, pioneered by Nufabrx®, is a market category that integrates medication and textiles to create wearable clothing and simplify health and wellness for consumers. The first product line available at retailers nationwide embeds a topical analgesic pain reliever into apparel, to heal aches and pains on-the-go. The product line enables clothing to enhance patient compliance of medications simply by getting dressed in the morning. For more information, visit https://nufabrx.com/.

About Enventys Partners
Enventys Partners is the industry's only full-service, turnkey product launch agency. They combine start-to-finish, all-encompassing product development services with digital marketing expertise to create innovative products and bring them to market. As a global leader in product development and marketing with four offices in the US and one in Asia, Enventys Partners designs, prototypes, manufactures, fulfills, crowdfunds, and markets new products and startup businesses. Enventys Partners has raised more than $500 million for clients through crowdfunding, $1 billion in product sales and has been involved in the development, prototyping, launching, and/or marketing of over 3,500 products. For more than 20 years, clients have utilized the agency's combined services to take their consumer product from napkin sketch to production. For more information, visit https://enventyspartners.com/.

Media Contact

Matt Harris, Enventys Partners, 704-313-9319, [email protected]

SOURCE Enventys Partners

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.